Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: Approaching target selectivity by de novo drug design
Autor/-in: Fischer, Thomas
Gazzola, Silvia
Riedl, Rainer
et. al: No
DOI: 10.1080/17460441.2019.1615435
Erschienen in: Expert Opinion on Drug Discovery
Band(Heft): 14
Heft: 8
Seiten: 791
Seiten bis: 803
Erscheinungsdatum: 10-Jun-2019
Verlag / Hrsg. Institution: Taylor & Francis
ISSN: 1746-0441
Sprache: Englisch
Schlagwörter: Drug design; Fragment-based drug design; Ligand-based drug design; Medicinal chemistry; Selectivity; Structure-based drug design; Drug development; Drug discovery; Humans; Ligands; Structure-activity relationship; Molecular targeted therapy
Fachgebiet (DDC): 615: Pharmakologie und Therapeutik
Zusammenfassung: Introduction: The development of drug candidates with a defined selectivity profile and a unique molecular structure is of fundamental interest for drug discovery. In contrast to the costly screening of large substance libraries, the targeted de novo design of a drug by using structural information of either the biological target and/or structure-activity relationship data of active modulators offers an efficient and intellectually appealing alternative. Areas covered: This review provides an overview on the different techniques of de novo drug design (ligand-based drug design, structure-based drug design, and fragment-based drug design) and highlights successful examples of this targeted approach toward selective modulators of therapeutically relevant targets. Expert opinion: De novo drug design has established itself as a very efficient method for the development of potent and selective modulators for a variety of different biological target classes. The ever-growing wealth of structural data on therapeutic targets will certainly further enhance the importance of de novo design for the drug discovery process in the future. However, a consistent use of the terminology of de novo drug design in the scientific literature should be sought.
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: Life Sciences und Facility Management
Organisationseinheit: Institut für Chemie und Biotechnologie (ICBT)
Enthalten in den Sammlungen:Publikationen Life Sciences und Facility Management

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.

Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.